Antihuman leukocyte antigen antibody-induced autoimmunity: Role in chronic rejection

Current Opinion in Organ Transplantation

Volumn 15, Issue 1, 2010, Pages 16-20

  Nath, Dilip S ^a   Basha, Haseeb Illias ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunity; Autoimmunity; Self antigens

Indexed keywords

ALPHA TUBULIN; ANGIOTENSIN 1 RECEPTOR; AUTOANTIGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; GAMMA INTERFERON; HISTOCOMPATIBILITY ANTIGEN; LEUKOCYTE ANTIBODY; LEUKOCYTE ANTIGEN; MYC PROTEIN; MYOSIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VIMENTIN;

ALLOIMMUNITY; AUTOIMMUNITY; CARDIAC ALLOGRAFT VASCULOPATHY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; NONHUMAN; REVIEW; TH17 CELL;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; ISOANTIBODIES; ORGAN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 75749156319     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283342780     Document Type: Review

References (40)

1. Illigens BM, Yamada A, Anosova N, et al. Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol 2009 [Epub ahead of print].
2. Li C, Yang CW. The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol 2009; 5:513-519.
3. Grossman EJ, Shilling RA. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res 2009; 153:153-165.
4. Kaczmarek I, Deutsch MA, Kauke T, et al. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp Clin Transplant 2008; 6:229-235.
5. Montecalvo A, Shufesky WJ, Stolz DB, et al. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 2008; 180:3081-3090.
6. Smyth LA, Harker N, Turnbull W, et al. The relative efficiency of acquisition of MHC: peptide complexes and cross-presentation depends on dendritic cell type. J Immunol 2008; 181:3212-3220.
7. Birnbaum LM, Lipman M, Paraskevas S, et al. Management of chronic allograft nephropathy: a systematic review. Clin J Am Soc Nephrol 2009; 4:860-865.
8. Hachem RR. Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant 2009 [Epub ahead of print].
9. Shilling RA, Wilkes DS. Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond. Am J Transplant 2009; 9:1714-1718.
10. Verleden GM, Vos R, De Vleeschauwer SI, et al. Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int 2009; 22:771-779.
11. Belperio JA, Weigt SS, Fishbein MC, Lynch JP 3rd. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 2009; 6: 108-121.
12. Jaramillo A, Smith MA, Phelan D, et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999; 67:1155-1161.
13. Yamada Y, Sekine Y, Yoshida S, et al. Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 2009; 183:237-245.
14. Kuo E, Maruyama T, Fernandez F, Mohanakumar T. Molecular mechanisms of chronic rejection following transplantation. Immunol Res 2005; 32: 179-185.
15. Smith CR, Jaramillo A, Duffy BF, Mohanakumar T. Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection. Hum Immunol 2000; 61:985-992.
16. Bharat A, Narayanan K, Street T, et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007; 83:150-158.
17. Sato M, Hirayama S, Hwang DM, et al. The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation. J Immunol 2009; 182:7307-7316.
18. Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009; 182:309-318.
19. Reddy PR, Gulati A, Steen L, et al. Outcomes of bare metal versus drugeluting stents in allograft vasculopathy. J Heart Lung Transplant 2008; 27:1222-1228.
20. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report 2006. J Heart Lung Transplant 2006; 25:869-879.
21. Jindra PT, Hsueh A, Hong L, et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 2008; 180:2214-2224.
22. Brennan TV, Hoang V, Garrod KR, et al. A new T-cell receptor transgenic model of the CD4p direct pathway: level of priming determines acute versus chronic rejection. Transplantation 2008; 85:247-255.
23. Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28:213-225.
24. Atz ME, Reed EF. Role of anti-MHC class I antibody in facilitating transplant accommodation. Crit Rev Immunol 2008; 28:485-511.
25. Rose ML, Smith JD. Clinical relevance of complement-fixing antibodies in cardiac transplantation. Hum Immunol 2009; 70:605-609.
26. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205:3133-3144.
27. Tuuminen R, Nykanen AI, Krebs R, et al. PDGF-A,-C, and-D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts. Arterioscler Thromb Vasc Biol 2009; 29:691-698.
28. Hasegawa T, Iwanaga K, Hultquist DE, et al. Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy. Am J Physiol Heart Circ Physiol 2009; 296:H1007-H1016.
29. Hertig A, Anglicheau D, Verine J, et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008; 19:1584-1591.
30. Yang L, Lu YP, Luo GH, et al. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy. Transplant Proc 2008; 40:2786-2789.
31. Lee PC, Zhu L, Terasaki PI, Everly MJ. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 2009; 88:568-574.
32. Turgeon NA, Kirk AD, Iwakoshi NN. Differential effects of donor-specific alloantibody. Transplant Rev (Orlando) 2009; 23:25-33.
33. Stastny P, Ring S, Lu C, et al. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol 2009; 70:600-604.
34. Goers TA, Ramachandran S, Aloush A, et al. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008; 180:4487-4494.
35. Iwata T, Philipovskiy A, Fisher AJ, et al. Antitype V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008; 181:5738-5747.
36. Bharat A, Fields RC, Steward N, et al. CD4p25p regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 2006; 6:1799-1808.
37. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117:3498-3506.
38. Leong HS, Mahesh BM, Day JR, et al. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor. J Leukoc Biol 2008; 83:263-271.
39. Kauke T, Kaczmarek I, Dick A, et al. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients. J Heart Lung Transplant 2009; 28:305-311.
40. Fotheringham J, Angel CA, McKane W. Transplant glomerulopathy: morphology, associations and mechanism. Nephron Clin Pract 2009; 113:c1-c7.